Publication | Closed Access

A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients

Heart FailureIron MetabolismPharmacologyHematologyDeferasirox TreatmentMedicine5-Year Follow-upCardiologyThalassemia Major PatientsOxidative Stress